Aimovig Approval in More and More Countries
Little by little, the new migraine drug Aimovig (erenumab) is being approved around the world. Places such as Canada, Australia, and the EU are moving to get Aimovig on the shelf for consumers, while other places continue to work through the approval process.
If you’re just catching up on the new drugs entering the market, here are some articles to help you out:
- Big News: First CGRP Inhibitor for migraine Approved in US – Aimovig – an overview of how Aimovig is used, dosage, etc.
- More Positive Results from the CGRP Migraine Treatments – from June 2017 (before Aimovig/erenumab was approved), but a helpful overview of some of the other drugs on the way.
- The Secret of CGRP – from waaaay back in 2012, a slightly lighthearted introduction to this type of treatment, long before any of this class were approved.
- After anti-CGRP Drugs to fight Migraine: anti-PAC 1? – these are no miracle drugs – so what’s next? Researchers are already looking ahead.